However, we failed to demonstrate any significant anti-inflammatory effects of Y2 inhibition, and instead provide evidence that Y2 receptor signaling may play a role in promoting IBD-related visceral pain. The gene discussed is PSMB8; the disease is inflammatory bowel disease.